AIM
RARE icon

Assured Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Assured Investment Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,770
Closed -$331K – 678
2016
Q2 		$331K Buy
+6,770
New +$438K 0.01% 452
2015
Q4 		– Sell
-575
Closed -$55K – 708
2015
Q3 		$55K Buy
+575
New +$65.8K ﹤0.01% 575

Other funds holding RARE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Assured Investment Management's RARE Position: Q3 2016 in Review

Assured Investment Management sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2016, closing a stake of 6,770 shares — an estimated $331K sold.

Assured Investment Management first reported a position in RARE in Q3 2015 and held it in 2 quarters. The position peaked at $331K in Q2 2016. 172 funds tracked by Wall St. Rank hold RARE as of Q3 2016.

  • Assured Investment Management reported no remaining Ultragenyx Pharmaceutical position as of Q3 2016 after selling out during the quarter.
  • Assured Investment Management sold 6,770 Ultragenyx Pharmaceutical shares in Q3 2016, an estimated $331K.
  • Assured Investment Management first reported a position in Ultragenyx Pharmaceutical in Q3 2015 and held it in 2 quarters.
  • Assured Investment Management's Ultragenyx Pharmaceutical position peaked at $331K in Q2 2016.
  • 172 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2016.

Based on Assured Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.